| Product NDC: | 25010-710 | 
| Proprietary Name: | Syprine | 
| Non Proprietary Name: | trientine hydrochloride | 
| Active Ingredient(s): | 250 mg/1 & nbsp; trientine hydrochloride | 
| Administration Route(s): | ORAL | 
| Dosage Form(s): | CAPSULE | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 25010-710 | 
| Labeler Name: | Aton Pharma, Inc. | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | NDA019194 | 
| Marketing Category: | NDA | 
| Start Marketing Date: | 19851108 | 
| Package NDC: | 25010-710-15 | 
| Package Description: | 1 BOTTLE in 1 CARTON (25010-710-15) > 100 CAPSULE in 1 BOTTLE | 
| NDC Code | 25010-710-15 | 
| Proprietary Name | Syprine | 
| Package Description | 1 BOTTLE in 1 CARTON (25010-710-15) > 100 CAPSULE in 1 BOTTLE | 
| Product NDC | 25010-710 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | trientine hydrochloride | 
| Dosage Form Name | CAPSULE | 
| Route Name | ORAL | 
| Start Marketing Date | 19851108 | 
| Marketing Category Name | NDA | 
| Labeler Name | Aton Pharma, Inc. | 
| Substance Name | TRIENTINE HYDROCHLORIDE | 
| Strength Number | 250 | 
| Strength Unit | mg/1 | 
| Pharmaceutical Classes | Metal Chelating Activity [MoA],Metal Chelator [EPC] |